Cutaneous adverse events (CAEs) to GLP-1 agonists were retrospectively reviewed using the FDA Adverse Event Reporting System (FAERS)
The molecular and structural/functional changes translate to (1) Tubular atrophy, podocyte hypertrophy, glomerulosclerosis, and microvascular rarefaction and (2) glomerular basement membrane thickening, nephrosclerosis, and extracellular matrix accumulation, respectively [84]
Glaucoma Hyperthyroidism High blood pressure A history of seizures Eating disorders History of some thyroid cancers What to Expect at a Weight Loss Consultation A healthy diet Regular exercise Stress management Mental health treatment Weight Loss Medications Dont Work Alone The Takeaway When taken alongside a healthy diet and regular exercise, prescription weight loss medications can help you lose weight if lifestyle changes alone arent giving you the results you want
Hospira bacteriostatic water available as a single sealed vial for qualified buyers and permitted use
In December 2025, WW launched a standalone GLP-1 Success program for members whose prescriptions come from outside providers, positioning the company as the support layer around GLP-1s regardless of where the script originates
The use of EGCG as a clinical agent for neurodegenerative diseases still requires further evaluation of toxicity and dosage
